Menu

Filtros : "Nova Zelândia" "American journal of cardiovascular drugs" Removido: "CNRS Guyane USR3456, Immeuble Le Relais, 2 Avenue Gustave Charlery, 97300, Cayenne, French Guiana" Limpar

Filtros

Refine with date range

  • 1

1 - 3 (3 records)

  • Artigo de periodico

    Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes Mellitus and Cardiovascular Disease: The Past, Present, and Future (2022)

    Ferrari, Filipe; Scheffel, Rafael S.; Martins, Vitor M.; Santos Filho, Raul Dias dos ; Stein, Ricardo

    Source: American journal of cardiovascular drugs. Unidade: FM

    Subjects: DIABETES MELLITUS, DOENÇAS CARDIOVASCULARES, FATORES DE RISCO

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      FERRARI, Filipe et al. Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes Mellitus and Cardiovascular Disease: The Past, Present, and Future. American journal of cardiovascular drugs, v. 22, n. 4, p. 363-383, 2022Tradução . . Disponível em: https://doi.org/10.1007/s40256-021-00515-4. Acesso em: 02 jun. 2024.

    • APA

      Ferrari, F., Scheffel, R. S., Martins, V. M., Santos Filho, R. D. dos, & Stein, R. (2022). Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes Mellitus and Cardiovascular Disease: The Past, Present, and Future. American journal of cardiovascular drugs, 22( 4), 363-383. doi:10.1007/s40256-021-00515-4

    • NLM

      Ferrari F, Scheffel RS, Martins VM, Santos Filho RD dos, Stein R. Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes Mellitus and Cardiovascular Disease: The Past, Present, and Future [Internet]. American journal of cardiovascular drugs. 2022 ; 22( 4): 363-383.[citado 2024 jun. 02 ] Available from: https://doi.org/10.1007/s40256-021-00515-4

    • Vancouver

      Ferrari F, Scheffel RS, Martins VM, Santos Filho RD dos, Stein R. Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes Mellitus and Cardiovascular Disease: The Past, Present, and Future [Internet]. American journal of cardiovascular drugs. 2022 ; 22( 4): 363-383.[citado 2024 jun. 02 ] Available from: https://doi.org/10.1007/s40256-021-00515-4

  • Artigo de periodico

    Addressing Major Unmet Needs in Patients with Systolic Heart Failure: The Role of Ivabradine (2016)

    Pereira-Barretto, Antonio Carlos

    Source: American journal of cardiovascular drugs. Unidade: FM

    Subjects: PROGNÓSTICO, BIOMARCADORES, FÁRMACOS (SISTEMA CARDIOVASCULAR), INSUFICIÊNCIA CARDÍACA

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      PEREIRA-BARRETTO, Antonio Carlos. Addressing Major Unmet Needs in Patients with Systolic Heart Failure: The Role of Ivabradine. American journal of cardiovascular drugs, v. 16, n. 2, p. 93-101, 2016Tradução . . Disponível em: http://link.springer.com/article/10.1007/s40256-016-0159-2. Acesso em: 02 jun. 2024.

    • APA

      Pereira-Barretto, A. C. (2016). Addressing Major Unmet Needs in Patients with Systolic Heart Failure: The Role of Ivabradine. American journal of cardiovascular drugs, 16( 2), 93-101. doi:10.1007/s40256-016-0159-2

    • NLM

      Pereira-Barretto AC. Addressing Major Unmet Needs in Patients with Systolic Heart Failure: The Role of Ivabradine [Internet]. American journal of cardiovascular drugs. 2016 ; 16( 2): 93-101.[citado 2024 jun. 02 ] Available from: http://link.springer.com/article/10.1007/s40256-016-0159-2

    • Vancouver

      Pereira-Barretto AC. Addressing Major Unmet Needs in Patients with Systolic Heart Failure: The Role of Ivabradine [Internet]. American journal of cardiovascular drugs. 2016 ; 16( 2): 93-101.[citado 2024 jun. 02 ] Available from: http://link.springer.com/article/10.1007/s40256-016-0159-2

  • Artigo de periodico

    A Vaccine against Streptococcus pyogenes (2013)

    Guilherme, Luiza; Ferreira, Frederico Moraes; Köhler, Karen Francine; Postol, Edilberto; Kalil, Jorge

    Source: American journal of cardiovascular drugs. Unidade: FM

    Subjects: INFECÇÕES ESTAFILOCÓCICAS (MORTALIDADE), FEBRE REUMÁTICA, GLOMERULONEFRITE, MODELOS ANIMAIS, AUTOIMUNIDADE

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      GUILHERME, Luiza et al. A Vaccine against Streptococcus pyogenes. American journal of cardiovascular drugs, v. 13, n. 1, p. 1-4, 2013Tradução . . Disponível em: http://link.springer.com/content/pdf/10.1007%2Fs40256-013-0005-8. Acesso em: 02 jun. 2024.

    • APA

      Guilherme, L., Ferreira, F. M., Köhler, K. F., Postol, E., & Kalil, J. (2013). A Vaccine against Streptococcus pyogenes. American journal of cardiovascular drugs, 13( 1), 1-4. doi:10.1007%2Fs40256-013-0005-8

    • NLM

      Guilherme L, Ferreira FM, Köhler KF, Postol E, Kalil J. A Vaccine against Streptococcus pyogenes [Internet]. American journal of cardiovascular drugs. 2013 ; 13( 1): 1-4.[citado 2024 jun. 02 ] Available from: http://link.springer.com/content/pdf/10.1007%2Fs40256-013-0005-8

    • Vancouver

      Guilherme L, Ferreira FM, Köhler KF, Postol E, Kalil J. A Vaccine against Streptococcus pyogenes [Internet]. American journal of cardiovascular drugs. 2013 ; 13( 1): 1-4.[citado 2024 jun. 02 ] Available from: http://link.springer.com/content/pdf/10.1007%2Fs40256-013-0005-8
  • 1

1 - 3 (3 records)

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024